EV/EBITDA
-30.62
+2.34+7.10%
Fri, 28 Feb 2025 22:31:40 GMT
Summary
- As of March 2, 2025, RAPP EV/EBITDA is -30.62, with a rise of +2.34 (+7.10%) during the most recent trading day.
- RAPP EV/EBITDA is now at all-time high.
Performance
RAPP EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
RAPP EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
|---|---|---|---|
| todaytoday | +7.1% | -7.1% | -7.0% |
| 1 m1 month | +31.1% | -31.1% | -30.8% |
| 3 m3 months | +55.8% | -55.8% | -55.4% |
| 6 m6 months | +58.3% | -50.1% | -50.5% |
| ytdytd | +44.1% | -44.1% | -43.7% |
| 1 y1 year | - | - | - |
| 5 y5 years | - | - | - |
RAPP EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | at high | -56.83 | +46.1% | |
| 3 m | 3-month | -30.62 | at high | -74.29 | +58.8% |
| 6 m | 6-month | -30.62 | at high | -90.59 | +66.2% |
| 1 y | 1-year | -30.62 | at high | -125.55 | +75.6% |
| 3 y | 3-year | -30.62 | at high | -125.55 | +75.6% |
| 5 y | 5-year | -30.62 | at high | -125.55 | +75.6% |
| alltime | all time | -30.62 | at high | -125.55 | +75.6% |
Rapport Therapeutics EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | -30.62(-44.1%) |
| Date | Value |
|---|---|
| 2024 | -54.77 |
FAQ
- What is Rapport Therapeutics EV/EBITDA?
- What is the all time high EV/EBITDA for Rapport Therapeutics?
- What is RAPP EV/EBITDA year-to-date change?
What is Rapport Therapeutics EV/EBITDA?
The current EV/EBITDA of RAPP is -30.62
What is the all time high EV/EBITDA for Rapport Therapeutics?
Rapport Therapeutics all-time high EV/EBITDA is -30.62
What is RAPP EV/EBITDA year-to-date change?
Rapport Therapeutics EV/EBITDA has changed by +24.15 (+44.09%) since the beginning of the year